RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Windtree Therapeutics Stock

Windtree Therapeutics Net Income 2024

Windtree Therapeutics Net Income

-71.39 M USD

Ticker

WINT

ISIN

US97382D3035

WKN

A2P3ZQ

In 2024, Windtree Therapeutics's profit amounted to -71.39 M USD, a 251.81% increase from the -20.29 M USD profit recorded in the previous year.

The Windtree Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-
2006-
2005-
2004-

Windtree Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Windtree Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Windtree Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Windtree Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Windtree Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Windtree Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Windtree Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Windtree Therapeutics’s growth potential.

Windtree Therapeutics Revenue, EBIT and net profit per share

DateWindtree Therapeutics RevenueWindtree Therapeutics EBITWindtree Therapeutics Net Income
2029e0 undefined0 undefined-437.32 M undefined
2028e0 undefined-48.14 M undefined-383.33 M undefined
2027e0 undefined-41.11 M undefined-340.14 M undefined
2026e180.91 M undefined-36.11 M undefined-18.3 M undefined
2025e0 undefined-28.05 M undefined-63.89 M undefined
2024e0 undefined-19.89 M undefined-71.39 M undefined
20230 undefined-17.54 M undefined-20.29 M undefined
20220 undefined-21.89 M undefined-39.21 M undefined
20210 undefined-32.26 M undefined-67.64 M undefined
20200 undefined-30.32 M undefined-32.57 M undefined
2019198,000 undefined-24.89 M undefined-27.48 M undefined
20181.79 M undefined-16.2 M undefined-34.76 M undefined
20171.49 M undefined-22.55 M undefined-24.82 M undefined
20162.04 M undefined-38.04 M undefined-39.49 M undefined
2015987,000 undefined-39.83 M undefined-55.17 M undefined
20142.84 M undefined-43.26 M undefined-44.06 M undefined
2013388,000 undefined-44.51 M undefined-45.22 M undefined
2012195,000 undefined-37.82 M undefined-37.32 M undefined
2011582,000 undefined-24.51 M undefined-20.97 M undefined
20100 undefined-25.53 M undefined-19.18 M undefined
20090 undefined-29.2 M undefined-29.87 M undefined
20084.6 M undefined-38.39 M undefined-39.11 M undefined
20070 undefined-39.95 M undefined-40.01 M undefined
20060 undefined-42.1 M undefined-46.33 M undefined
2005134,000 undefined-59.3 M undefined-58.9 M undefined
20041.21 M undefined-37.91 M undefined-46.2 M undefined

Windtree Therapeutics stock margins

The Windtree Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Windtree Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Windtree Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Windtree Therapeutics's sales revenue. A higher gross margin percentage indicates that the Windtree Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Windtree Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Windtree Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Windtree Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Windtree Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Windtree Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Windtree Therapeutics Margin History

Windtree Therapeutics Gross marginWindtree Therapeutics Profit marginWindtree Therapeutics EBIT marginWindtree Therapeutics Profit margin
2029e100 %0 %0 %
2028e100 %0 %0 %
2027e100 %0 %0 %
2026e100 %-19.96 %-10.11 %
2025e100 %0 %0 %
2024e100 %0 %0 %
2023100 %0 %0 %
2022100 %0 %0 %
2021100 %0 %0 %
2020100 %0 %0 %
2019100 %-12,572.22 %-13,876.26 %
2018100 %-905.76 %-1,943.85 %
2017100 %-1,518.38 %-1,671.11 %
2016100 %-1,862.68 %-1,933.89 %
20155.88 %-4,035.87 %-5,589.67 %
20145.78 %-1,525.86 %-1,554.07 %
2013-33.25 %-11,471.13 %-11,653.35 %
2012-747.18 %-19,394.36 %-19,135.9 %
2011100 %-4,211.68 %-3,602.23 %
2010100 %0 %0 %
2009100 %0 %0 %
2008100 %-834.65 %-850.13 %
2007100 %0 %0 %
2006100 %0 %0 %
2005100 %-44,250 %-43,958.21 %
2004100 %-3,135.32 %-3,821.59 %

Windtree Therapeutics Aktienanalyse

What does Windtree Therapeutics do?

Windtree Therapeutics is an emerging biotechnology company based in Pittsburgh, Pennsylvania. The company was founded in 2011 and specializes in the development of innovative therapies for respiratory diseases. Windtree Therapeutics aims to improve the lives of millions of people worldwide by providing effective and safe medications. History: Windtree Therapeutics has a history that dates back to 1990 when it was founded as Advanced Inhalation Research, focusing on the development of therapies for respiratory diseases. After several rounds of financing and mergers, the company was eventually revived as Windtree Therapeutics. Since then, the company has developed and marketed a range of innovative therapies that improve the lives of millions of patients with respiratory diseases. Business model: Windtree Therapeutics is a biotechnology company focused on the development and commercialization of therapies for respiratory diseases. The company has a strong ethos for innovation and works closely with leading medical and scientific experts to develop high-quality and safe products. The company holds a variety of patents and unique technologies that allow it to improve its competitive position in the industry. Segments: Windtree Therapeutics operates in two business segments: PneumRX® Bronchial Tubes and KL4-Surfactant Technology. PneumRX® Bronchial Tubes: One of Windtree Therapeutics' main segments is the PneumRX® Bronchial Tube technology. This technology aims to improve the lives of patients with chronic obstructive pulmonary disease (COPD). The PneumRX® tubes are used as minimally invasive procedures to open the lumen of the bronchial tubes and facilitate breathing. The technology has already been used in thousands of patients worldwide and is highly regarded by physicians. KL4-Surfactant Technology: Windtree Therapeutics is also known for its KL4-Surfactant Technology, which aims to treat respiratory distress syndrome in newborns. The company has already conducted a number of clinical studies, and the results have been very promising. The KL4-Surfactant Technology is considered one of the most promising treatment options for respiratory problems in newborns. Products: Windtree Therapeutics has a range of products on the market, including: Aer-OS Nitric Oxide Inhalation Device: The Aer-OS Nitric Oxide Inhalation Device is a medical device for patients with pulmonary hypertension. It is the first and only portable nitric oxide inhalation device approved for use at home and on-the-go. The device is used to facilitate breathing and improve patients' quality of life. PneumRX® Bronchial Tubes: The PneumRX® Bronchial Tube technology has already been performed in thousands of patients and is highly regarded by physicians. The technology aims to open the lumen of the bronchial tubes and facilitate breathing. The procedures are minimally invasive and result in minimal injuries. Patients often experience significant improvement in their breathing and overall well-being. KL4-Surfactant Technology: Windtree Therapeutics' KL4-Surfactant Technology is a promising treatment option for respiratory problems in newborns. The technology aims to stimulate lung growth and facilitate breathing. The results of clinical studies have been very promising, and the treatment is considered one of the most promising treatment options for respiratory problems in newborns. In conclusion, Windtree Therapeutics is an emerging biotechnology company with a strong ethos for innovation and the development of therapies for respiratory diseases. The PneumRX® Bronchial Tube technology and KL4-Surfactant Technology are two of the company's main segments. Both technologies are promising and have the potential to improve the lives of millions of patients worldwide. Windtree Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Windtree Therapeutics's Profit Margins

The profit margins of Windtree Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Windtree Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Windtree Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Windtree Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Windtree Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Windtree Therapeutics stock

How much profit has Windtree Therapeutics made this year?

Windtree Therapeutics has made -71.39 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 251.81% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Windtree Therapeutics publish its earnings?

Windtree Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Windtree Therapeutics?

The profits of Windtree Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Windtree Therapeutics?

You can learn more about the earnings of Windtree Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Windtree Therapeutics pay?

Over the past 12 months, Windtree Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Windtree Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Windtree Therapeutics?

The current dividend yield of Windtree Therapeutics is .

When does Windtree Therapeutics pay dividends?

Windtree Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Windtree Therapeutics?

Windtree Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Windtree Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Windtree Therapeutics located?

Windtree Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Windtree Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Windtree Therapeutics from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Windtree Therapeutics pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Windtree Therapeutics in the year 2023?

In the year 2023, Windtree Therapeutics distributed 0 USD as dividends.

In which currency does Windtree Therapeutics pay out the dividend?

The dividends of Windtree Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Windtree Therapeutics

Our stock analysis for Windtree Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Windtree Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.